News updates
-
08 OCT
ACE-inhibitors and psoriasis
The Netherlands Pharmacovigilance Centre Lareb received 25 reports of aggravation of psoriasis or new-onset psoriasis in association with Angiotensin Converting E...
-
19 AUG
Increased number of adverse drug reactions associated with oxaliplatin
During the last year, the Netherlands Pharmacovigilance Centre Lareb sees an increase in the number of reports of advers...
-
18 AUG
Noscapine and angioedema
Noscapine is an Over-The-Counter (OTC) drug. It is used as treatment of (a nonproductive) tickling cough and is also the drug of first choice when a cough depressant ...
-
27 JUL
Isotretinoin (Roaccutane) and erectile dysfunction
Isotretinoin is used as a treatment for severe types of acne, that prove resistant to standard therapy. Lareb received 7 reports on erectile...
-
22 JUL
Selective serotonergic vasoconstrictors (triptans) and pain re-activation
The Netherlands Pharmacovigilance Centre Lareb received 19 reports of pain re-activation in association with selectiv...
-
12 JUN
Fluconazole and Fixed Drug Eruption
Lareb received 13 reports of fixed drug eruptions (FDE) in association with fluconazole. Fluconazole is used in fungal infections, including Candida. A Fix...
-
07 MAY
The first Lareb conference on patient reporting was held on April 23-24 in Leiden, the Netherlands
The conference was attended by 60 participants from 21 different counties. During the confer...
-
25 MAR
Good healthcare requires more attention for adverse drug reactions
Adverse Drug Reactions (ADRs) can have a major impact on the health and well-being of patients. Unfortunately, sufficient at...
-
05 MAR
ACE-inhibitors and hallucinations
The Netherlands Pharmacovigilance Centre Lareb received 15 reports of hallucinations associated with the use of ACE-inhibitors. ACE-inhibitors involved were ...